I am a
Home I AM A Search Login

Papers of the Week

2019 Sep

Can J Anaesth



Correlation between incremental remifentanil doses and the Nociception Level (NOL) index response after intraoperative noxious stimuli.


Renaud-Roy E, Stöckle P-A, Maximos S, Brulotte V, Sideris L, Dubé P, Drolet P, Tanoubi I, Issa R, Verdonck O, Fortier L-P, Richebé P
Can J Anaesth. 2019 Sep; 66(9):1049-1061.
PMID: 30997633.


The Pain Monitoring Device (PMD) monitor (Medasense Biometrics Ltd., Ramat Gan, Israel) uses the Nociception Level (NOL) index, a multiple parameter-derived index that has recently shown a good sensitivity and specificity to detect noxious stimuli. The aim of this study was to assess the latest version of the device (PMD200) on variations of the NOL response after standardized tetanic stimuli to study the correlation between remifentanil doses and NOL.